This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wood, G. S. Articles by Kikuchi, M. Search for Related Content PubMed PubMed Citation Articles by Wood, G. S. Articles by Kikuchi, M.

American Journal of Pathology, Vol 150, 667-673, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

No evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphoma

GS Wood, JM Schaffer, R Boni, R Dummer, G Burg, M Takeshita and M Kikuchi
Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.

Several recent studies have reported detection of HTLV-I genetic sequences in patients with cutaneous T-cell lymphoma (CTCL) including mycosis fungoides and Sezary syndrome. The purpose of this study was to determine whether HTLV-I was detectable in lesional tissues of patients suffering from diseases known to be associated with CTCL. Thirty-five cases were obtained from diverse geographical locations including Ohio, California, Switzerland, and Japan. Six of them had concurrent CTCL. Cases were analyzed using a combination of genomic polymerase chain reaction (PCR)/ Southern blot, dot blot, and Southern blot analyses. All assays were specific for HTLV-I provirus. Sensitivity ranged from approximately 10(-6) for PCR-based studies to 10(-2) for unamplified genomic blotting. Lesional DNA from patients with lymphomatoid papulosis (fourteen cases), Hodgkin's disease (twelve cases), and CD30+ large-cell lymphoma (nine cases) was tested for the HTLV-I proviral pX region using a genomic PCR assay followed by confirmatory Southern blot analysis with a nested oligonucleotide pX probe. All cases were uniformly negative. All of the Hodgkin's disease cases, eight of the large-cell lymphoma cases, and six of the lymphomatoid papulosis cases were then subjected to dot blot analysis of genomic DNA using a full- length HTLV-I proviral DNA probe that spans all regions of the HTLV-I genome. Again, all cases were negative. Finally, eleven of the Hodgkin's disease cases were also subjected to Southern blot analysis of EcoRI-digested genomic DNA using the same full-length HTLV-I probe. Once again, all cases were negative. These findings indicated that, despite utilization of a variety of sensitive and specific molecular biological methods, HTLV-I genetic sequences were not detectable in patients with CTCL-associated lymphoproliferative disorders. These results strongly suggest that the HTLV-I retrovirus is not involved in the pathogenesis of these diseases.

This article has been cited by other articles:

				M.-w. Su, I. Dorocicz, W. H. Dragowska, V. Ho, G. Li, N. Voss, R. Gascoyne, and Y. Zhou Aberrant Expression of T-Plastin in Sezary Cells Cancer Res., November 1, 2003; 63(21): 7122 - 7127. [Abstract] [Full Text] [PDF]

				L. Tracey, R. Villuendas, A. M. Dotor, I. Spiteri, P. Ortiz, J. F. Garcia, J. L. R. Peralto, M. Lawler, and M. A. Piris Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study Blood, August 1, 2003; 102(3): 1042 - 1050. [Abstract] [Full Text] [PDF]

				W. Kempf, M. E. Kadin, A. M. Dvorak, C. C. Lord, G. Burg, N. L. Letvin, and I. J. Koralnik Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin Carcinogenesis, February 1, 2003; 24(2): 301 - 306. [Full Text] [PDF]

				D. Zucker-Franklin ; and U. Dobbeling The role of interleukin-7 and interleukin-15 in cutaneous T-cell lymphoma Blood, May 1, 2002; 99(9): 3488 - 3489. [Full Text] [PDF]

				G. Burg, R. Dummer, A. Haeffner, W. Kempf, and M. Kadin From Inflammation to Neoplasia: Mycosis Fungoides Evolves From Reactive Inflammatory Conditions (Lymphoid Infiltrates) Transforming Into Neoplastic Plaques and Tumors Arch Dermatol, July 1, 2001; 137(7): 949 - 952. [Full Text] [PDF]

				R. S. Siegel, T. Pandolfino, J. Guitart, S. Rosen, and T. M. Kuzel Primary Cutaneous T-Cell Lymphoma: Review and Current Concepts J. Clin. Oncol., August 15, 2000; 18(15): 2908 - 2925. [Abstract] [Full Text] [PDF]

				An Update on Treating Cutaneous T-Cell Lymphoma Journal Watch Dermatology, April 1, 1999; 1999(401): 10 - 10. [Full Text]